Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as poor memory and attention, which are considered core symptoms for the illness.2 Current evidence also suggests that neuroinflammation, a byproduct of neurotransmitter dysfunctions as a results of increased pro-inflammatory cytokines, may play a role in cognitive dysfunction and neurodegeneration in serious mental illnesses, such as schizophrenia.1
Recent evidence suggests that cognitive deficits may be present even before the onset of illness, …
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Existing MembersAlready A Member? Log In
New MembersJoin To View
Join PsychU Today at no cost for access to this and other premium content.
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you’re interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders